• 
• 
• 
• 

Activity Overview

Please read the following information about this continuing pharmacy education (CPE) activity before accessing the presentations using links located at the bottom of this page.

Accreditation for Pharmacists

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity provides 2 hours (0.2 CEUs) of continuing pharmacy education credit (ACPE activity #204-000-09-430-H01P).

Methods and Format

This is an online activity consisting of audio and slides for three presentations, a post-test, and an activity evaluation tool. Participants should claim continuing education credit for this internet-based educational activity only if they have not claimed credit for the live activity. Participants must view all presentations, take the activity post-test, and complete the course evaluation to receive continuing pharmacy education credit. A minimum score of 70% is required on the test for credit to be awarded, and participants may print their official statements of continuing pharmacy education credit immediately. The estimated time to complete this activity is 2 hours. This activity is provided free of charge.

Target Audience

This continuing pharmacy education activity was planned to meet the needs of pharmacists in a variety of practice settings, including large and small health systems, outpatient clinics, managed-care organizations, long-term care facilities, and academia. This activity would be particularly beneficial for pharmacists, clinical specialists, managers, leaders, and educators who are interested in new drug therapies, women's health, preventive medicine, ambulatory care, and oncology.

Activity Content

Click here to view an overview of the activity content.

Learning Objectives

After participating in this knowledge-based CPE activity, participants should be able to

• Identify methods and issues related to promoting bone health and screening for osteoporosis based on clinical guidelines, patient risk factors, and proper use of the World Health Organization's fracture risk algorithm (FRAX).
• Identify patients who are candidates for osteoporosis treatment based on recent guidelines from the National Osteoporosis Foundation.
• Describe current and emerging therapeutic options for the prevention and treatment of osteoporosis in postmenopausal women.
• Describe the rationale for monitoring the bone health of patients with breast or prostate cancer undergoing hormone ablation therapy.
• Describe current and emerging therapeutic options to decrease bone loss in patients with breast or prostate cancer undergoing hormone ablation therapy.
• Identify at least three ways that pharmacists can help improve the quality of bone health initiatives in their institutions.
• Discuss elements of successful patient education related to bone health.

Faculty

Eric J. MacLaughlin, Pharm.D., FCCP, BCPS
Activity Chair
Associate Professor and Head of Adult Medicine Division
School of Pharmacy
Texas Tech University Health Sciences Center
Amarillo, Texas

Laura Boehnke Michaud, Pharm.D., FASHP, BCOP
Clinical Pharmacy Specialist
Manager, Clinical Pharmacy Services
The University of Texas M. D. Anderson Cancer Center
Houston, Texas

Sheryl F. Vondracek, Pharm.D., FCCP, BCPS
Associate Professor
Department of Clinical Pharmacy
University of Colorado Denver School of Pharmacy
Aurora, Colorado

Disclosure Statement

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Guidelines for Standards for Commercial Support, ASHP Advantage requires that all individuals involved in the development of activity content disclose their relevant financial relationships and that conflicts of interest be identified and resolved prior to delivery of the activity.

The faculty and planners report the following relationships:

This activity is supported by an educational donation provided by Amgen.

Launch Presentation*

Overview of Bone Health and Risk Assessment (25 minutes)
Eric J. MacLaughlin, Pharm.D., FCCP, BCPS


The “Obvious”: Promoting Bone Health in Postmenopausal Women (40 minutes)
Sheryl F. Vondracek, Pharm.D.,FCCP, BCPS


The “Not-So-Obvious”: Promoting Bone Health in Patients Receiving Therapy for Breast or Prostate Cancer (40 minutes)
Laura Boehnke Michaud, Pharm.D., FASHP, BCOP

Questions and Answers
(optional, not required for self-assessment test)
All Faculty (10 min)

*Allow additional time to complete the post-test and evaluation.

Download Post-Test

Click here to print the post-test for your reference. Please note that to be eligible for continuing pharmacy education credit, you must go to the ASHP Learning Center and complete the test online.

Additional Resources

For additional information about this topic or to sign-up to be notified when new resources are available, visit www.ashpadvantage.com/bonehealth.